Escherichia coli SA53 produces a new enterotoxin that has a biological activity similar to that of E. coli heat-labile enterotoxin (LT) but is not neutralized by antiserum against LT or cholera enterotoxin. Strain SA53 contained two plasmids, pRB1 (69.2 ± 4.3 megadaltons) and pRB2 (57.6 ± 5.3 megadaltons). Studies were undertaken to determine whether either plasmid was required for production of the LT-like toxin. We isolated a derivative of SA53 lacking both plasmids and confirmed that radioactively labeled pRB1 and pRB2 DNAs failed to hybridize to total DNA digests of the cured strain. The new enterotoxin was still produced by the cured strain, demonstrating that the gene(s) encoding the toxin was not located on pRB1 or pRB2 and was most likely on the bacterial chromosome. Although sonic extracts from SA53 contained no detectable LT antigen, plasmid pRB1 DNA did contain sequences with partial homology to the LT-A and LT-B genes. No sequence homology with LT genes was detected with pRB2 DNA. When the enterotoxin plasmid pCG86 was introduced into a rifampin-resistant derivative of SA53, LT was produced. Thus, plasmid-coded LT could be produced in the E. coli SA53 host, and the sequences homologous to LT in pRB1 were cryptic.
total DNA digests of the cured strain. The new enterotoxin was still produced by the cured strain, demonstrating that the gene(s) encoding the toxin was not located on pRB1 or pRB2 and was most likely on the bacterial chromosome. Although sonic extracts from SA53 contained no detectable LT antigen, plasmid pRB1 DNA did contain sequences with partial homology to the LT-A and LT-B genes. No sequence homology with LT genes was detected with pRB2 DNA. When the enterotoxin plasmid pCG86 was introduced into a rifampin-resistant derivative of SA53, LT was produced. Thus, plasmid-coded LT could be produced in the E. coli SA53 host, and the sequences homologous to LT in pRB1 were cryptic.
Enterotoxin-producing Escherichia coli strains have been identified as the causative agents of several important diarrheal diseases in animals and humans (9, 31) . Some of the E. coli strains associated with diarrheal diseases have been shown to produce heat-labile enterotoxin (LT) or heat-stable enterotoxin (ST) or both (12) , or a Shigella dysenteriae type 1-like cytotoxin (27) . Recent studies in our laboratory have identified a new cell-associated toxin produced from E. coli SA53 that resembles LT in its biological activity but is antigenically unrelated to LT (R. K. Holmes, E. M. Twiddy, and R. J. Neill, in Y. Takeda [ed.], Bacterial Diarrheal Disease: an International Symposium, in press). The new toxin is not neutralized by hyperimmune antisera prepared against purified LT from porcine or human E. coli strains or against purified cholera enterotoxin (CT). This new toxin has been partially purified and characterized. It is heat labile, activated by treatment with trypsin, induces rounding of Y1 adrenal cells, and produces elevated levels of cyclic AMP in these cells. For convenience, we will refer to t Present address: Walter Reed Army Institute of Research, Division of Biochemistry, Washington, DC 20012. this new toxin as LT-like toxin. A more detailed report on the chemical properties and biological activities of LT-like toxin will be presented elsewhere (R. K. Holmes and E. M. Twiddy, manuscript in preparation).
The purpose of the studies reported here was to characterize the genetic control of LT-like toxin production by E. coli SA53. Our results demonstrated that the genetic determinants for LT-like toxin are not plasmid associated and are most likely on the chromosome of E. coli SA53. We also showed that strain SA53 contains two indigenous plasmids, one of which has sequences homologous to structural genes for classical LT. These LT sequences are apparently cryptic, because E. coli SA53 did not produce detectable amounts of classical LT. 
a Nomenclature and symbols are as follows. Genetically controlled requirements for growth factors: isoleucine and valine (ilv), histidine (his), leucine (leu), methionine (met), phenylalanine (phe), proline (pro), pyrimidine (pyrC7), thiamine (thi), threonine (thr), and tryptophan (trp). hsdR, Mutation in host restriction activity, endonuclease R; supE44, mutation in amber suppressor; lac, inability to utilize lactose. Genetically controlled resistances to antibiotics and heavy metals: Ampr, ampicillin; Kanr, kanamycin; Merr, mercury; Nalr, nalidixic acid; Rif, rifampin; Strr or rpsL, streptomycin; Sulr, sulfonamides; Tetr, tetracycline.
Media and cultivation conditions. Luria (L) broth was used for routine liquid cultures (22 (10) .
Agarose gel electrophoresis. Electrophoretic separation of plasmid DNA and restriction fragments was performed in agarose (Sigma) gels buffered with Trisborate, pH 8.3 (89 mM Tris, 89 mM boric acid, 2.5 mM EDTA) (11) . Bacterial strains were screened for plasmid content by the in-well lysis technique of Eckhardt (8) or the rapid plasmid extraction procedure of Kado and Liu (14) .
Preparation 32P-labeled DNA probes for LT gene sequences. DNA sequences to by used as probes for structural genes for E. coli LT-A and -B polypeptides were prepared from the recombinant plasmid EWD299 as described by Mosley and Falkow (24) . DNA fragments were extracted from low-melting-temperature agarose (FMC Corp., Rockland, Maine) gels by the method of Langridge et al. (17) . A RESULTS In this study, we set out to ascertain the location of the structural genes encoding the LTlike toxin in E. coli SA53. First, we characterized the plasmids in this strain. E. coli SA53 has two indigenous plasmids (Fig. 1, lane 3; Fig. 2) . The larger plasmid, pRB1 ( Fig. 2A) , has a mass of 69.2 + 4.3 Mdal, and the smaller plasmid, pRB2 (Fig. 2B) , has a mass of 57.6 + 5.3 Mdal, as measured by electron microscopy (Fig. 3) . Strain SA53 was susceptible to all antibiotics tested, including tetracycline, ampicillin, kanamycin, streptomycin, gentamicin, nalidixic acid, and chloramphenicol. Therefore, neither pRB1 nor pRB2 contains determinants for resistance to these antibiotics. Since LT genes are frequently plasmid encoded in E. coli (9, 12), we tested for possible sequence homology between plasmid pRB1 or pRB2 and LT gene probes derived from p307. The DNA of plasmid pRB1 contained sequences that hybridized with DNA probes corresponding to the LT-B and the LT-A genes (Fig. 4, lanes A2, A4, and B4) . Hybridization of the LT-B probe with pRB1 occurred under the most stringent conditions tested (50% formamide at 37°C); hybridization of the LT-A probe was not detected under similar conditions but did occur under less stringent conditions (20% formamide at 37°C) (Fig. 4B, lanes 2 and  4) . The slight hybridization of the LT-B probe in the region of chromosomal DNA (Fig. 4A , lanes 2 and 4) was presumably due to fragments of pRB1 because no hybridization was observed in control experiments with DNA from strains HE105 or HE106 which were cured of pRB1. The failure of the LT gene probes to hybridize with DNA from strain HE105 in control experiments also demonstrated that plasmid pRB2 has no sequences with detectable homology to these probes.
To facilitate genetic studies on the plasmids pRB1 and pRB2, we attempted to label them by the insertion of transposon Tnl, which codes for ampicillin resistance. Insertion of Tnl into pRB2 was confirmed by a slight decrease in the electrophoretic mobility of pRB4 as compared with pRB2 (Fig. 1, lanes 3-5) and by analysis of EcoRI restriction endonuclease fragments of pRB2 and pRB4 (data not shown). Plasmid pRB4 was transferred from E. coli HE103 to the E. coli K-12 derivative HE110 by conjugation. Strains SA53 and HE103 produced LT-like toxin, but strain HE11O(pRB4) did not (Table 2) . 
EB
were homologous with the structural genes for LT were functional or cryptic. A sensitive solid-2 3 4 1 2 3 4 phase radioimmunoassay was used to test for antigens in sonic extracts of SA53 that crossreacted with the E. coli LT encoded by pCG86, but none was detected (Table 3) . To exclude the possibility that plasmid-coded LTs cannot be *~made in strain SA53, we introduced the conjugative enterotoxin plasmids pCG86, TP235Km, and TP237Tc, originally isolated from E. coli strains of porcine and human origin, into the rifampin-resistant SA53 derivative HE102 by conjugation. The additional data in Table 3 demonstrate that the LTs encoded by these plasmids can be synthesized in both E. coli HE102 and the E. coli K-12 control strain KL320. However, the yields of LT in HE102 were 5-to 10-fold less
FIG. 4. Hybridization of LT-B (A)
and LT-A (B) probes to plasmids isolated from E. coli SA53. Hybridizations in lanes 1 and 2 were carried out in 50% formamide at 37°C; hybridizations in lanes 3 and 4 were carried out in 20% formamide at 37°C. Plasmid DNAs were prepared by the method of Birnboim and Doly (1) from E. coli 711(p3O7) and SA53. The DNA samples were as follows: lanes 1 and 3, p307; lanes 2 and 4, a mixture of pRB1 and pRB2.
These observations indicated that plasmid pRB2 and its derivative pRB4 did not determine production of the LT-like toxin.
Next, we investigated the role of plasmid pRB1 in toxinogenesis. Efforts to label plasmid pRB1 by inserting transposon Tnl and to mobilize it into an E. coli K-12 strain were unsuccessful. However, we did succeed in isolating cured derivatives of SA53 lacking both pRB1 and pRB2 (strain HE106) or lacking pRB1 only (strain HE105) (Fig. 1, lanes 1 and 2) . When sonic extracts of HE105 and HE106 were tested for LT-like toxin in Y1 adrenal cells, the specific toxicities were comparable to those of extracts from wild-type SA53 ( Table 2 ). The LT-like toxin produced by strains SA53, HE105, and HE106 was not neutralized by hyperimmune anti-LT or anti-CT, although these antisera did neutralize the classical LT produced by E. coli KL320(pCG86) ( Table 2 ). To confirm that the cured strain HE106 did not contain chromosomal DNA sequences derived from pRB1 or pRB2, we labeled purified pRB1 and pRB2 with 32P and demonstrated that they failed to hybridize with EcoRI digests of total DNA from strain HE106 (data not shown). Similar methods were used to confirm that HE105 was cured of pRB1. These observations provide direct evidence that the LT-like toxin can be produced by E. coli SA53 derivatives lacking both plasmids.
Additional experiments were performed to determine whether the sequences on pRB1 that inan nIuse in 11 /-u. 1 nus, tn1C sequences o pRB1 that are homologous with LT structural genes appear to be cryptic, but LT can be produced in the SA53 background when functional enterotoxin plasmids are present.
DISCUSSION
In recent years, the number of enterotoxins known to be produced by E. coli strains has been increasing. In addition to the classical LT and ST (9, 31) , production of an S. dysenteriae type 1-like cytotoxin has recently been described by O'Brien et al. (27) . We have recently reported the existence of an LT-like toxin pro- (14) . Therefore, the genetic determinants for LT-like toxin are not located on plasmid pRB1 or pRB2 in E. coli SA53 and are most likely chromosomal. Further studies will be needed to identify the structural gene(s) coding for the LT-like toxin and to determine its location on the genetic map of the E. coli chromosome. The possibility that the structural gene(s) for LT-like toxin could be located on a prophage or a transposon in the bacterial chromosome has not been excluded.
DNA probes corresponding to the structural genes for the A and B polypeptides of LT did not hybridize with chromosomal DNA from E. coli HE106, which is cured of resident plasmids but continues to produce LT-like toxin. These findings indicate that the structural gene(s) for the LT-like toxin does not have extensive sequence homology with the structural genes for the A and B polypeptides of classical LT. In contrast, the LT gene probes do hybridize with sequences in all LT-producing E. coli strains tested (23, 25) , although some degree of antigenic diversity is known to exist among LTs from E. coli strains of human and porcine origin (13, ation when LT gene probes are used diagnostically. It is conceivable that such cryptic sequences could lead to false-positive diagnoses of enterotoxigenic E. coli strains. There is a need for additional epidemiological studies to determine the incidence of E. coli strains that produce LT-like toxin or have cryptic LT gene sequences.
Finally, although LT-like toxin resembles LT in its biological activities and mode of action, the possible role of LT-like toxin in the pathogenesis of diseases in humans and animals remains to be established.
